Skip to content

3iDea: what changed

What changed

3iDea

BE 0716.659.160
NACE 72.101, Research and development on biotechnology
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€1,207
2024 · €1,244-€38
Equity
€113,822
2024 · €112,615+€1,207
Cash
€148
2024 · €4,653-€4,505
Balance sheet total
€253,951
2024 · €252,244+€1,706

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€15,176

    up €15,176 (+829%), from €1,830 to €17,007

    of which Trade receivables: +€16,182

  • Tangible fixed assets -€5,673

    down €5,673 (-29.9%), from €18,954 to €13,281

    of which Furniture and vehicles: -€4,013

  • Cash -€4,505

    down €4,505 (-96.8%), from €4,653 to €148

    mainly Receivables within one year (-€15,176) and Accrued charges and deferred income (-€3,860)

  • Stocks and contracts -€3,476

    down €3,476 (-31.6%), from €10,987 to €7,511

Equity and liabilities
  • Other debts +€6,022

    up €6,022 (+4.7%), from €128,549 to €134,571

  • Accrued charges and deferred income -€3,860

    down €3,860 (-100%), from €3,860 to €0

Income statement
  • Financial income -€7,947

    down €7,947 (-99.4%), from €7,998 to €51

  • Write-downs -€7,849

    down €7,849, from €3,924 to -€3,924

  • Financial charges -€6,257

    down €6,257 (-97.3%), from €6,429 to €173

  • Other operating charges +€4,296

    up €4,296 (+642%), from €669 to €4,965

  • Depreciation +€1,236

    up €1,236 (+20.2%), from €6,105 to €7,341

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €1,244
Gross operating margin -€1,233
Depreciation -€1,236
Write-downs +€7,849
Other operating charges -€4,296
Financial income -€7,947
Financial charges +€6,257
Taxes +€569
Result 2025 €1,207
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€2,836
Investment -€1,669
Financing €0
Cash 2024 €4,653
Net result for the year +€1,207
Depreciation +€7,341
Stocks and contracts +€3,476
Receivables within one year -€15,176
Deferred charges and accrued income -€183
Trade debts -€967
Tax, wage and social debts -€695
Other debts +€6,022
Accrued charges and deferred income -€3,860
Investment in fixed assets (net) -€1,669
Cash 2025 €148
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €252,244 €253,951 +€1,706 +0.7%
Fixed assets 21/28 €234,554 €228,881 -€5,673 -2.4%
Tangible fixed assets 22/27 €18,954 €13,281 -€5,673 -29.9%
Furniture and vehicles 24 €9,837 €5,824 -€4,013 -40.8%
Other tangible fixed assets 26 €9,117 €7,457 -€1,660 -18.2%
Financial fixed assets 28 €215,600 €215,600 = 0.0%
Current assets 29/58 €17,690 €25,070 +€7,379 +41.7%
Stocks and contracts in progress 3 €10,987 €7,511 -€3,476 -31.6%
Stocks 30/36 €10,987 €7,511 -€3,476 -31.6%
Amounts receivable within one year 40/41 €1,830 €17,007 +€15,176 +829%
Trade receivables 40 €824 €17,007 +€16,182 +1,964%
Other amounts receivable 41 €1,006 €0 -€1,006 -100%
Current investments 50/53 €0 - =
Cash at bank and in hand 54/58 €4,653 €148 -€4,505 -96.8%
Deferred charges and accrued income 490/1 €221 €404 +€183 +83.0%
Total equity and liabilities 10/49 €252,244 €253,951 +€1,706 +0.7%
Equity 10/15 €112,615 €113,822 +€1,207 +1.1%
Contributions 10/11 €1,000 €1,000 = 0.0%
Contributions outside capital 11 €1,000 - -€1,000
Other 1109/19 €1,000 - -€1,000
Reserves 13 €111,615 €112,822 +€1,207 +1.1%
Distributable reserves 133 €111,615 €112,822 +€1,207 +1.1%
Amounts payable 17/49 €139,629 €140,129 +€500 +0.4%
Amounts payable within one year 42/48 €135,769 €140,129 +€4,360 +3.2%
Trade debts 44 €3,021 €2,053 -€967 -32.0%
Suppliers 440/4 €3,021 €2,053 -€967 -32.0%
Taxes, remuneration and social security 45 €4,199 €3,505 -€695 -16.5%
Taxes 450/3 €4,199 €2,295 -€1,905 -45.4%
Remuneration and social security 454/9 - €1,210 +€1,210
Other amounts payable 47/48 €128,549 €134,571 +€6,022 +4.7%
Accrued charges and deferred income 492/3 €3,860 €0 -€3,860 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,105 €7,341 +€1,236 +20.2%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €3,924 -€3,924 -€7,849
Other operating charges 640/8 €669 €4,965 +€4,296 +642%
Gross operating margin 9900 €12,409 €11,176 -€1,233 -9.9%
Operating profit (loss) 9901 €1,710 €2,793 +€1,083 +63.3%
Financial income 75/76B €7,998 €51 -€7,947 -99.4%
Recurring financial income 75 €7,998 €51 -€7,947 -99.4%
Financial charges 65/66B €6,429 €173 -€6,257 -97.3%
Recurring financial charges 65 €6,429 €173 -€6,257 -97.3%
Profit (loss) for the period before taxes 9903 €3,279 €2,672 -€607 -18.5%
Income taxes 67/77 €2,035 €1,466 -€569 -28.0%
Profit (loss) for the period 9904 €1,244 €1,207 -€38 -3.0%
Profit (loss) for the period to be appropriated 9905 €1,244 €1,207 -€38 -3.0%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.